Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
RMD Open|June 30, 2018
Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritisVibeke Strand, Margaret Michalska, Christine Birchwood, et al.
Digital Health|September 18, 2024
Digital measurement of mobility in pulmonary arterial hypertension: A structured review of an emerging areaErin Robertson, Nader Naghavi, Matthew F Wipperman, et al.
Rheumatology and Therapy|February 2, 2019
Adverse Events in Giant Cell Arteritis and Rheumatoid Arthritis Patient Populations: Analyses of Tocilizumab Clinical Trials and Claims DataSara Gale, Huong Trinh, Katie Tuckwell, et al.
Rheumatology and Therapy|May 13, 2018
Risk Associated with Cumulative Oral Glucocorticoid Use in Patients with Giant Cell Arteritis in Real-World Databases from the USA and UKSara Gale, Jessica C Wilson, Jenny Chia, et al.
Seminars in Arthritis and Rheumatism|January 2, 2017
Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysisJessica C Wilson, Khaled Sarsour, Neil Collinson, et al.
Rheumatology and Therapy|December 26, 2022
Serious Infection Rates Among Patients with Select Autoimmune Conditions: A Claims-Based Retrospective Cohort Study from Taiwan and the USAWen-Nan Huang, Ching-Yi Chuo, Ching-Heng Lin, et al.
Seminars in Arthritis and Rheumatism|November 15, 2016
Incidence of outcomes potentially associated with corticosteroid therapy in patients with giant cell arteritisJessica C Wilson, Khaled Sarsour, Neil Collinson, et al.
Seminars in Arthritis and Rheumatism|December 22, 2016
Newly diagnosed vs. relapsing giant cell arteritis: Baseline data from the GiACTA trialKatie Tuckwell, Neil Collinson, Sophie Dimonaco, et al.
Rheumatology and Therapy|April 25, 2024
A Phase 1a Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7303509, an Anti-TGFβ3 Antibody, in Healthy VolunteersLyrialle W Han, Samira Jamalian, Joy C Hsu, et al.
The New England Journal of Medicine|July 27, 2017
Trial of Tocilizumab in Giant-Cell ArteritisJohn H Stone, Katie Tuckwell, Sophie Dimonaco, et al.
Pageof 3